Senior Accounting Manager, Asimov
Intelligent genetic design platform
Be an early applicant
Intelligent genetic design platform
21-100 employees
Be an early applicant
21-100 employees
Company mission
To empower the genetic designers who are building the future.
Role
Who you are
- The ideal candidate will thrive in a collaborative, science-driven environment while bringing financial rigor, process discipline, and forward-thinking leadership to drive innovation and fuel the company’s next phase of growth
- You have a Bachelor’s or Master’s degree in Accounting or Finance with 7+ years of progressive experience in accounting/finance. CPA certification is strongly preferred
- You ideally have prior life sciences, biotech, or high-growth tools/services experience
- You have strong technical accounting expertise, including revenue recognition, COGS tracking, accruals, and GAAP compliance
- You have experience with audits, tax compliance, and working directly with external auditors
- You are proficient with general ledger systems, procurement platforms, and financial reporting tools
- You’ve demonstrated the ability to build scalable accounting processes and internal controls in a high-growth company
- You have an analytical mindset with attention to detail; able to identify variances, trends, and risks early
- You have excellent communication skills, able to translate accounting into clear business insights
What the job involves
- We are seeking a strategic and hands-on Senior Accounting Manager to establish and lead our accounting operations
- In this newly created role, and reporting to the Head of Commercial, you will be responsible for ensuring accurate revenue recognition, supporting budgeting and forecasting, streamlining and implementing processes, while overseeing all accounts payable and receivable activities
- This role offers the unique opportunity to design and optimize financial systems from the ground up within a rapidly growing biotech startup
- Accounting & Controls: Ensure timely and accurate recording of revenue, COGS, and expenses across all product lines. Maintain reconciliations, accruals, and closing schedules
- Audit & Compliance: Lead preparation for the annual audit, liaise with auditors on technical issues (e.g., revenue recognition, asset classification), and ensure compliance with tax and regulatory requirements
- Budget Tracking: Monitor spend against budget, provide variance analyses, and maintain rolling forecasts with input from department leads
- Systems & Processes: Recommend and implement scalable general ledger and procurement systems (e.g., Prendio or equivalents) to improve reporting, visibility, and spend control
- Cash & Runway Visibility: Produce monthly cash flow reports, identify risks to runway, and flag required actions
- Reporting: Prepare accurate and timely monthly/quarterly financial statements, management reports, and supporting schedules for leadership and investors
- Payroll: Manage scalable payroll systems and processes, ensuring accuracy, timeliness, and compliance across multiple states, while partnering with HR to support an expanding and distributed workforce
Our take
Despite the many recent breakthroughs in medicine, drug manufacturing remains a lengthy and costly process that is difficult to scale. Asimov seeks to combat this with its intelligent design suite for synthetic biologists, that leverages computer-aided design to help design, simulate, and optimise genetic systems more reliably.
Asimov's platform consists of a fully integrated suite of cells, genes, and software that can be implemented in every step of the therapeutics creation process from initial design through to analysis. By accelerating the speed at which biologists can test and improve their drugs, the company hopes to help bring innovative treatments to market faster and thus advance the standard of treatment for patients.
Having secured considerable funding, Asimov is looking to scale its business in biologics, advanced cell/gene therapies, and RNA. It will also use the investment to expand research and development into new areas of synthesis, as well as grow its team.
Steph
Company Specialist at Welcome to the Jungle
Company
Funding (last 2 of 3 rounds)
Jan 2023
$175m
SERIES B
Dec 2019
$25m
SERIES A
Total funding: $204.7m
Company HQ
West Fens, Boston, MA
Leadership
Chris Voigt
(Co-Founder)Board Member at the Novo Nordisk Foundation, MIT Professor, and Co-Founder of Pivot Bio.
Douglas Densmore
(Co-Founder)Professor at Boston University. Previously co-founded BioSens8 and Lattice Automation.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at Asimov